{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:47:26Z","timestamp":1793195246756,"version":"4.5.0"},"reference-count":36,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Overactive bladder (OAB) is a syndrome of the lower urinary tract characterized by urinary urgency, frequency, and nocturia, with or without urgency urinary incontinence. OAB significantly impacts all aspects of life\u2014social, psychological, physical, professional, domestic, and sexual\u2014for both women and men. The aim of this study was to investigate sexual dysfunction in both women and men with OAB treated with intravesical onabotulinumtoxinA (Botox) injections using the Sexual Quality of Life questionnaire in two versions: female (SQoL-F) and male (SQoL-M). Methods: Forty sexually active patients (thirty women and ten men) with idiopathic OAB were recruited. Patients completed the SQoL-F or SQoL-M questionnaire before treatment, and again at 3 and 6 months after treatment with intravesical onabotulinumtoxinA injections. Results: All 40 patients completed the study (30 women and 10 men). There were no statistically significant differences in SQoL results before the procedure or at 3- and 6-months post-treatment. Conclusions: OAB treatment with onabotulinumtoxinA did not significantly affect the quality of sexual life in either women or men. Further research is needed using questionnaires specifically designed to assess the sexual life of patients with OAB, especially in men.<\/jats:p>","DOI":"10.3390\/jcm13195869","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T07:41:49Z","timestamp":1727768509000},"page":"5869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sexual Dysfunction in Patients with Overactive Bladder Syndrome Treated with Botulinum Toxin"],"prefix":"10.3390","volume":"13","author":[{"given":"Joanna","family":"Sondka-Migdalska","sequence":"first","affiliation":[{"name":"1st Department of Urology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Blaszczynski","sequence":"additional","affiliation":[{"name":"Psychology Department, Pirogow Regional Hospital in Lodz, 90-001 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0962-7868","authenticated-orcid":false,"given":"Zbigniew","family":"Jablonowski","sequence":"additional","affiliation":[{"name":"1st Department of Urology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol. Urodyn."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00192-012-1682-6","article-title":"Pathophysiology of overactive bladder","volume":"23","author":"Banakhar","year":"2012","journal-title":"Int. Urogynecol. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1442-2042.2007.01905.x","article-title":"Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder","volume":"15","author":"Oh","year":"2008","journal-title":"Int. J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2011.07.049","article-title":"Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States","volume":"61","author":"Coyne","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_8","first-page":"30","article-title":"The overactive bladder and quality of life","volume":"50","author":"Epstein","year":"2005","journal-title":"Int. J. Fertil. Women\u2019s Med."},{"key":"ref_9","first-page":"376","article-title":"Le syndrome d\u2019hyperactivit\u00e9 v\u00e9sicale [The overactive bladder syndrome]","volume":"78","author":"Verjans","year":"2023","journal-title":"Rev. Med. Liege"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.euf.2021.08.011","article-title":"Choosing the most efficacious and safe oral treatment for idiopathic overactive bladder: A systematic review and network meta-analysis","volume":"8","author":"Mostafaei","year":"2022","journal-title":"Eur. Urol. Focus"},{"key":"ref_11","first-page":"79","article-title":"OnabotulinumtoxinA for the treatment of overactive bladder","volume":"6","author":"Cox","year":"2014","journal-title":"Res. Rep. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2051415812473096","article-title":"Botulinum toxin-A for the treatment of overactive bladder: UK contributions","volume":"6","author":"Seth","year":"2013","journal-title":"J. Clin. Urol."},{"key":"ref_13","first-page":"CD005493","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","volume":"12","author":"Duthie","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_14","unstructured":"World Health Organization, Department of Reproductive Health and Research (2020, May 06). Developing Sexual Health Programmes: A Framework for Action WHO\/RHR\/HRP\/10.22. Available online: https:\/\/iris.who.int\/handle\/10665\/70501."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1879-5226(11)60002-X","article-title":"Female sexual dysfunction: Physiology, epidemiology, classification, evaluation and treatment","volume":"22","author":"Tsai","year":"2011","journal-title":"Urol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.sxmr.2020.05.001","article-title":"The Evolution of the Female Sexual Disorder\/Dysfunction Definitions, Nomenclature, and Classifications: A Review of DSM, ICSM, ISSWSH, and ICD","volume":"9","author":"Parish","year":"2021","journal-title":"Sex. Med. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1743-6109.2007.00409.x","article-title":"Sexual dysfunctions: Classifications and definitions","volume":"4","author":"Hatzimouratidis","year":"2007","journal-title":"J. Sex. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","article-title":"Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence","volume":"29","author":"Abrams","year":"2010","journal-title":"Neurourol. Urodyn."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/00926230591006502","article-title":"Development of a Questionnaire on Sexual Quality of Life in Women","volume":"31","author":"Symonds","year":"2005","journal-title":"J. Sex Marital. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1743-6109.2006.00315.x","article-title":"Evaluating the impact of overactive bladder on sexual health in women: What is relevant?","volume":"4","author":"Coyne","year":"2007","journal-title":"J. Sex. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jsxm.2022.01.001","article-title":"Talking About Sexuality with Youth: A Taboo in Psychiatry?","volume":"19","author":"Bungener","year":"2022","journal-title":"J. Sex. Med."},{"key":"ref_22","first-page":"23","article-title":"Let\u2019s Talk About Sex: A Survey of Patients\u2019 Preferences When Addressing Sexual Health Concerns in a Family Medicine Residency Program Office","volume":"2","author":"Ryan","year":"2018","journal-title":"Peer-Rev. Rep. Med. Educ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/jwh.2018.7352","article-title":"Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications","volume":"28","author":"Kingsberg","year":"2019","journal-title":"J. Women\u2019s Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.36469\/9816","article-title":"Elicitation of Health-related Quality-of-life Concepts Associated with Overactive Bladder: A Qualitative Study","volume":"4","author":"Hawken","year":"2016","journal-title":"J. Health Econ. Outcomes Res."},{"key":"ref_25","first-page":"811","article-title":"Sexual quality of life and female sexual function in women after fetal death","volume":"93","author":"Bialek","year":"2022","journal-title":"Ginekol. Pol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cybulski, M., Cybulski, L., Krajewska-Kulak, E., Orzechowska, M., Cwalina, U., and Jasinski, M. (2018). Sexual quality of life, sexual knowledge, and attitudes of older adults on the example of inhabitants over 60s of Bialystok, Poland. Front. Psychol., 9.","DOI":"10.3389\/fpsyg.2018.00483"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Baszak-Radoma\u0144ska, E., Wa\u0144czyk-Baszak, J., and Paszkowski, T. (2024). Women\u2019s sexual health improvement: Sexual quality of life and pelvic floor muscle assessment in asymptomatic women. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1289418"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Evans, C.N.B., Badenhorst, A., and Van Wijk, F.J. (2024). The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: A systematic review. BMC Women\u2019s Health, 24.","DOI":"10.1186\/s12905-024-03103-1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00404-015-3828-5","article-title":"Impact of treatment of overactive bladder with anticholinergics on sexual function","volume":"293","author":"Jha","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/nau.23148","article-title":"Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB","volume":"36","author":"Miotla","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.sxmr.2019.05.002","article-title":"Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis","volume":"7","author":"Balzarro","year":"2019","journal-title":"Sex. Med. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00345-015-1578-4","article-title":"OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: Preliminary results","volume":"33","author":"Giannantoni","year":"2015","journal-title":"World J. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1111\/j.1743-6109.2008.01000.x","article-title":"Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men","volume":"5","author":"Irwin","year":"2008","journal-title":"J. Sex. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00345-024-04841-5","article-title":"Overactive bladder negatively affects erectile function and promotes premature ejaculation: Findings from large representative population-level study","volume":"42","author":"Przydacz","year":"2024","journal-title":"World J. Urol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/nau.24879","article-title":"Botulinum toxin for treating overactive bladder in men: A systematic review","volume":"41","author":"Truzzi","year":"2022","journal-title":"Neurourol. Urodyn."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.esxm.2019.08.013","article-title":"Overactive Bladder Syndrome Treatments and Their Effect on Female Sexual Function: A Review","volume":"8","author":"Levy","year":"2020","journal-title":"Sex. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:08:45Z","timestamp":1760112525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":36,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["jcm13195869"],"URL":"https:\/\/doi.org\/10.3390\/jcm13195869","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}